Miki Nishimura

1.6k total citations
49 papers, 1.1k citations indexed

About

Miki Nishimura is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Miki Nishimura has authored 49 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Miki Nishimura's work include Hematopoietic Stem Cell Transplantation (9 papers), Glycosylation and Glycoproteins Research (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Miki Nishimura is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Glycosylation and Glycoproteins Research (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Miki Nishimura collaborates with scholars based in Japan and United States. Miki Nishimura's co-authors include Yasushi Saitō, Chiaki Nakaseko, Akira Yokota, Emiko Sakaida, Yusuke Furukawa, Hideshi Ishii, Yutaka Furukawa, Keiichi Koizumi, Myoung-Sook Shin and Hiroaki Sakurai and has published in prestigious journals such as Blood, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Miki Nishimura

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miki Nishimura Japan 18 463 422 264 122 121 49 1.1k
Shrikanta Chattopadhyay United States 15 225 0.5× 580 1.4× 288 1.1× 114 0.9× 239 2.0× 25 1.5k
Yuping Gong China 20 268 0.6× 669 1.6× 231 0.9× 90 0.7× 64 0.5× 83 1.2k
Ruud Oerlemans Netherlands 13 305 0.7× 583 1.4× 445 1.7× 145 1.2× 41 0.3× 23 1.2k
M. H. Freedman Canada 19 468 1.0× 281 0.7× 363 1.4× 307 2.5× 84 0.7× 32 1.4k
Kourosh Lotfi Sweden 18 383 0.8× 400 0.9× 264 1.0× 108 0.9× 55 0.5× 54 968
Tarek H. Mouhieddine United States 18 230 0.5× 447 1.1× 457 1.7× 93 0.8× 121 1.0× 61 1.2k
Gertraud Fröschl Austria 15 401 0.9× 597 1.4× 269 1.0× 193 1.6× 40 0.3× 17 1.3k
Ahmad Ahmadzadeh Iran 15 174 0.4× 388 0.9× 230 0.9× 68 0.6× 57 0.5× 67 805
Young Cw United States 12 346 0.7× 640 1.5× 170 0.6× 63 0.5× 74 0.6× 22 972
T. C. M. Morris United Kingdom 16 364 0.8× 440 1.0× 283 1.1× 115 0.9× 39 0.3× 35 886

Countries citing papers authored by Miki Nishimura

Since Specialization
Citations

This map shows the geographic impact of Miki Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miki Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miki Nishimura more than expected).

Fields of papers citing papers by Miki Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miki Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miki Nishimura. The network helps show where Miki Nishimura may publish in the future.

Co-authorship network of co-authors of Miki Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Miki Nishimura. A scholar is included among the top collaborators of Miki Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miki Nishimura. Miki Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saruwatari, Junji, Tetsu Tomita, Shoko Tsuchimine, et al.. (2025). A MODELING APPROACH TO THE THERAPEUTIC EFFECT OF PAROXETINE FOR DEPRESSION WITH A FOCUS ON PHARMACOKINETICS- PHARMACODYNAMICS RELATIONSHIP. The International Journal of Neuropsychopharmacology. 28(Supplement_1). i189–i190.
2.
Tomita, Tetsu, Miki Nishimura, Tetsuya Kaneko, et al.. (2025). Effect of Cumulative Exposure on the Efficacy of Paroxetine: A Population Pharmacokinetic‐Pharmacodynamic and Machine Learning Analyses. CPT Pharmacometrics & Systems Pharmacology. 14(6). 1119–1127. 1 indexed citations
3.
Ito, Shin‐ichi, et al.. (2020). PROPOSAL OF THE METHOD ESTIMATING SEEPAGE ANALYSIS MODEL INCLUDING A BOUNDARY CONDITION USING MERGING PARTICLE FILTER. Journal of Japan Society of Civil Engineers Ser C (Geosphere Engineering). 76(1). 52–66.
4.
Nishimura, Miki, Junji Saruwatari, Akiko Aoki, et al.. (2016). Influence of the cytochrome P450 2D6 *10/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder. Pharmacogenetics and Genomics. 26(9). 403–413. 2 indexed citations
5.
Oniki, Kentaro, Miki Nishimura, Kazuki Matsuda, et al.. (2015). Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis. PLoS ONE. 10(10). e0141266–e0141266. 30 indexed citations
6.
7.
Suzuki, Takaaki, Masahiro Takeuchi, Shingo Yamazaki, et al.. (2010). Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy. Clinical Therapeutics. 32(3). 527–531. 10 indexed citations
8.
Sato, Emiko, Shouichi Ohga, Hiroshi Kuroda, et al.. (2008). Allogeneic hematopoietic stem cell transplantation for Epstein–Barr virus‐associated T/natural killer‐cell lymphoproliferative disease in Japan. American Journal of Hematology. 83(9). 721–727. 54 indexed citations
9.
Koizumi, Masayuki, Chiaki Nakaseko, Chikako Ohwada, et al.. (2007). Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone‐resistant myeloma cells. European Journal Of Haematology. 79(5). 382–391. 17 indexed citations
10.
Nakaseko, Chiaki, Miki Nishimura, Atsuo Maruta, et al.. (2007). Chronic graft‐versus‐host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. British Journal of Haematology. 137(2). 142–151. 44 indexed citations
11.
12.
Ishii, Hideshi, Andrea Vecchione, Yutaka Furukawa, et al.. (2003). Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.. PubMed. 1(13). 940–7. 59 indexed citations
13.
Chiba, Tetsuhiro, Osamu Yokosuka, Hiroshige Kojima, et al.. (2003). Chronic Graft-Versus-Host Disease Complicated by Acute Hepatitis B. Journal of Clinical Gastroenterology. 36(2). 179–181. 1 indexed citations
14.
Yokote, Koutaro, Chiaki Nakaseko, Kazuki Kobayashi, et al.. (2003). Bone Marrow-derived Vascular Cells in Response to Injury.. Journal of Atherosclerosis and Thrombosis. 10(4). 205–210. 20 indexed citations
15.
Chiba, Tetsuhiro, Osamu Yokosuka, Tatsuo Kanda, et al.. (2002). Hepatic graft‐versus‐host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid. Liver International. 22(6). 514–517. 8 indexed citations
16.
Nagata, Hiroshi, Tsutomu Numata, Akiyoshi Konno, et al.. (2001). Presence of natural killer‐cell clones with variable proliferative capacity in chronic active Epstein–Barr virus infection. Pathology International. 51(10). 778–785. 16 indexed citations
17.
Ohashi, Kazuteru, Juichi Tanabe, Reiko Watanabe, et al.. (2000). The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno‐occlusive disease after stem cell transplantation. American Journal of Hematology. 64(1). 32–38. 4 indexed citations
18.
Yokota, Akira, et al.. (1999). Potential use of serum CD44 as an indicator of tumour progression in acute leukemia. Hematological Oncology. 17(4). 161–168. 17 indexed citations
19.
Yokota, Akira, et al.. (1998). Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia. Hematological Oncology. 16(4). 131–141. 10 indexed citations
20.
Lutton, J. D., Miki Nishimura, Richard D. Levere, et al.. (1993). Coexpression of erythropoietin and heme oxygenase genes in Hep3B cells. Hepatology. 17(5). 861–868. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shrikanta Chattopadhyay Breakdown of academic impact, for papers by Yuping Gong Breakdown of academic impact, for papers by Ruud Oerlemans Breakdown of academic impact, for papers by M. H. Freedman Breakdown of academic impact, for papers by Kourosh Lotfi Breakdown of academic impact, for papers by Tarek H. Mouhieddine Breakdown of academic impact, for papers by Gertraud Fröschl Breakdown of academic impact, for papers by Ahmad Ahmadzadeh Breakdown of academic impact, for papers by Young Cw Breakdown of academic impact, for papers by T. C. M. Morris
Rankless by CCL
2026